Capital Flow Monitor · Sponsors · CIK 1797825
Aegle Therapeutics Corp
400 TRADECENTER, WOBURN, MA, 01801 · 781-918-8449
Biotechnology · Corporation· inc. DELAWARE true
Fit score
—
Offering
$2.3M
Sold
$2.3M
% sold
100.0%
Investors
17
Min investment
$0
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2026-08-28 | D ·current | 506(b) | $2.3M | $2.3M | 100.0% | 17 | EDGAR ↗ |
| 2026-03-03 | D | 506(b) | $700K | $456K | 65.1% | 10 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.
- Shelley Hartman — Executive Officer / Director, WOBURN, MA
- Scott Braunstein — Director, WOBURN, MA
- Leon Moulder — Director, WOBURN, MA
- Evangelos Badiavas — Director, WOBURN, MA
Placement agents
- No sales compensation reported — direct raise.
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.